Upadacitinib api2
2 Inquiries
2050057-56-0
Pharmaceutical Grade
99%
shanghai
Alicorn
25kg/Cardboard Drum
2023-09-22
Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Upadacitinib hemihydrate
Other Name:Upadacitinib hemihydrate;UNII-NEW4DV02U5;NEW4DV02U5;2050057-56-0;Rinvoq (TN);Upadacitinib hydrate (JAN);D11048;(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide hydrate(2:1);1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-E)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-;1831899-73-0
CAS No.:2050057-56-0
Molecular Formula:C34H40F6N12O3
InChIKeys:GJMQTRCDSIQEFK-SCDRJROZSA-N
Exact Mass:778.32505216
UNII:NEW4DV02U5
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod
-
Location:
Building 4, Juanhu Int. Sci & Innovation Park, No. 500, Shuiyueting East Road, Xishi Street, Haining, Jiaxing, Zhejiang
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
20
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
201-300
-
Year of Establishment:
2021
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
Pakistan
UPADACITINIB HEMIHYDRATE
225 G May 6, 2026 
South Korea
Upadacitinib Hemihydrate
100 G Mar 27, 2025 Post an enquiry for this product